The Dallas Mavericks (21-37) are set to host the Memphis Grizzlies (21-36) on Friday night in what promises to be a compelling matchup between two teams struggling to find their footing this season. Dallas is reeling from a surprising loss to the Sacramento Kings, while Memphis is entrenched in a losing streak, having dropped three straight games to Miami, Sacramento, and Golden State. Both teams seem to be racing toward the lottery, adding extra stakes to this encounter.
Injuries are a significant storyline for the Mavericks, who will be missing several key players. Kyrie Irving and Dereck Lively remain sidelined, while Cooper Flagg continues to recover from a foot injury. Marvin Bagley is also out after straining his neck in a recent fall against the Kings. Adding to their woes, four players—Moussa Cisse, Ryan Nembhard, Klay Thompson, and PJ Washington—are listed as doubtful, effectively ruling them out. Caleb Martin’s status remains uncertain due to a back injury.
The Grizzlies are not faring any better on the injury front, with notable absences including Ja Morant, Zach Edey, Cederic Coward, Brandon Clark, Kentavious Caldwell-Pope, Kyle Anderson, and Sani Aldama. Ty Jerome is labeled as doubtful, which brings the total number of unavailable players between both teams to an astonishing sixteen. This situation raises concerns about the competitive nature of the game.
Fatigue is also a factor for Dallas, with Naji Marshall logging heavy minutes as the team battles through their injury crisis. Memphis, on the other hand, has had a day of rest, while the Mavericks are coming off a game just the night before. While many expect this matchup to be less than aesthetically pleasing, there’s a belief that Dallas will find a way to stay competitive.
Fans are encouraged to share their predictions in the comments section.
Note: This recap is an independently written summary based on publicly available reporting.
TB
BOS
LAD
NYY
CHW
TOR
TEX
ATL
MIA
MIL
MIN
CHC
SD
KC
BAL
HOU
CIN
COL
DET
LAA
STL
ARI
WSH
OAK
SF
SEA
PIT
CLE
NYM
PHI